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ABSTRACT
The salivary proteome is recognized as a valuable source of potential oral and
systemic disease biomarkers. Major efforts in salivary research have been dedicated to
identify and characterize salivary proteins present in saliva using both classical
biochemical methods and proteomics approaches in adults. Despite considerable
research on the salivary proteome, little attention has been given to the changes in the
salivary proteome occurring in children, specifically from 0-3 years of age. Through the
use of anionic PAGE, SDS PAGE, HPLC and MS/MS, salivary protein profiles in
children before, during and after dental eruption were compared with edentulous adult
controls. We identified substantive qualitative and quantitative differences in the salivary
proteome between children and adults, suggesting a greater emphasis is warranted in
the study of the changes in the salivary proteome as a function of age and dental status.
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When you sense a thirst for knowledge,
why not
perform mouthwatering research?

When you feel the answer on the tip of your tongue,
why not
start by looking there?
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DEDICATION

For the reader, I hope you find all that you are looking for.

&

For Ma, Pa, S, and E, you are the very best.
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Chapter 1 – Literature Review
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1.1

Introduction to saliva

Saliva is indispensible in the maintenance of health and homeostasis in the body.
The critical importance of saliva is strikingly evident in individuals with reduced salivary
flow who experience: tooth decay/loss, acute irritation of oral mucosa, and severe
difficulties with airflow, speaking, swallowing, food clearance and taste. Saliva’s utility
extends still further, far beyond the oral cavity, with the discovery of oral and systemic
disease biomarkers in saliva. The use of salivary biomarkers as diagnostic tools must
be preceded by a clear understanding of salivary biochemistry in different conditions
and throughout the stages of life.
Saliva is defined as the mixture of fluid, organic, and inorganic components
derived in large part from salivary gland secretions, the gingival fold, oral mucosa,
desquamated epithelial cells, blood cells, food, and microorganisms (1-7). The complex
composition of saliva reflects the dynamic equilibrium that exists between host, external
forces and microbial flora present in the oral cavity (8). The large inter- and intraindividual variation present in the salivary biochemical composition throughout the life
stages poses both a challenge to understanding saliva’s biochemical properties, but
also a tremendous opportunity to uncover stage-specific biological data potentially
relevant in the clinical setting (9-12).
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From a biochemical perspective, it is recognized that proteins in saliva represent
a rich source of relevant biological information (6). Great effort has been dedicated to
identifying the proteins present in adult saliva (4, 7, 13-25). Despite the magnitude of
research devoted to salivary proteomic research, few have studied the salivary
proteome in children (26-29). In order to address this deficit and develop a deeper
understanding of the salivary proteome at different life stages, this thesis is focused on
the protein profile of saliva in children as their primary dentition erupts, from the ages of
0 to 3 years.
1.2

Overview of the salivary glands

Salivary glands are responsible for producing and actively secreting proteincontaining fluid into the oral cavity. These secretions represent an important contribution
to whole saliva (30, 31). Salivary glands are classified into two categories: major and
minor (30).
The major salivary glands contribute approximately 90% of the fluid present in
whole saliva. The three paired major salivary glands are: the parotid, submandibular,
and sublingual glands (30). The minor salivary glands supply approximately 10% of the
fluid present in whole saliva. There are an estimated 400-600 minor salivary glands in
the oral cavity. They are located in the mucosa of most of the soft tissue surfaces in the
mouth, including the cheeks, lips, palate and tongue (lingual/Von Ebner glands) (6, 31,
32).
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1.2.1 Salivary gland anatomy
The parotid gland, the largest of the major salivary glands, is located near the
mandibular ramus and provides mainly serous fluids through the Stenson’s duct that
opens into the oral environment near the second upper molars. The submandibular
gland is located near the lower jaw bone and provides mostly serous fluids through the
Wharton’s duct that opens to the oral environment near the junction of the tongue and
the floor of the mouth. The sublingual gland is located near the submandibular gland
and provides mainly mucous fluids through the Bartholin’s duct that opens to the oral
environment near the junction of the tongue and the floor of the mouth in close
association with the Wharton’s duct. A schematic illustrating the anatomy of the major
salivary glands and the associated ducts is found in Figure 1.1.
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Figure 1.1 – Anatomy of the major salivary gland and associated ducts. This schematic depicts
the location and form of the major salivary glands (parotid, submandibular and sublingual) and
the corresponding ducts (Stenson’s, Wharton’s, and Bartholin’s) through which glandular saliva
is introduced into the oral cavity.
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1.2.2 Salivary gland histology
Salivary glands contain two types of epithelial cells: Ductal and Acinar. Ductal
cells are primarily involved in establishing the ionic composition of the glandular
secretions. Ductal cells alter the electrolyte content of the fluid originating from the
acinar cells primarily by reabsorbing sodium chloride (33, 34). Ductal cells also secrete
proteins, although far fewer than acinar cells (34). Acinar cells make up the acini, the
secretory endpiece of the salivary gland ductal trees.

Acinar cells function by

synthesizing and secreting the majority of the functionally significant host-derived
salivary proteins, as well as actively transporting water and electrolytes (31).
Acinar cells are classified into two categories: Serous and mucous. The type of
secretion produced by a gland is determined by the ratio of serous to mucous acinar
cells (6, 31). Serous acinar cells secrete a proteinaceous, watery fluid, largely lacking
mucus. They are present in the parotid, submandibular, palatal, and lingual glands.
Mucous acinar cells secrete a mucous-rich substance, with high viscosity and elasticity.
They are present in the submandibular, sublingual, labial, palatal, and lingual glands (6).
1.3

Regulation of salivary secretion

Health and homeostasis of the oral environment depends greatly on the
presence of saliva and its protein composition. In order to maintain this vital role,
salivary flow is under the control of both the parasympathetic and sympathetic branches
of the autonomic nervous system (31). Both branches positively regulate flow from
salivary glands (35). The type of stimulation determines the ratio of activation between
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the two branches of autonomic control. In healthy individuals, resting or ‘unstimulated’
salivary flow rate is approximately 0.4 mL/min with a standard deviation of 0.21 mL/min.
In contrast, ‘stimulated’ salivary flow rate is approximately 1.6 mL/min with a standard
deviation of 2.1 mL/min. It is important to note the high standard deviations in both the
‘unstimulated’ and ‘stimulated’ saliva, as this reflects the wide range of normal healthy
values in salivary secretion (3).
Parasympathetic control of salivary secretion
Parasympathetic innervation is responsible for initiating salivary secretion and
maintaining high secretion rates (35). Cholinergic parasympathetic nerves innervate all
salivary glands. Parasympathetic stimulation of muscarinic cholinergic and alphaadrenergic receptors on the parotid salivary glands leads to a high flow rate of a fluid
containing low protein and high ion concentrations. Parasympathetic stimulation can be
sustained over long periods and accounts for the majority of salivation control. Baseline
amounts of salivary fluid and protein secretion are maintained at a ‘resting’ or
‘unstimulated’ rate in the absence of appropriate stimuli. (31).
Sympathetic control of salivary secretion
Sympathetic nerves are unable to initiate or maintain secretions independently.
Rather, these nerves potentiate parasympathetic effects through the release of
noradrenaline targeted at stimulating alpha- and beta-adrenergic receptors on acinar
and ductal cells to induce the release of stored proteins (31, 35). The presence of
stimuli (i.e. mastication) leads to a drastic increase in salivary flow, up to ten fold,
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signaled by sympathetic stimulation. Sympathetic stimulation is short-lived, releasing
large amounts of digestive enzymes and macromolecules such as mucin, which help
lubricate and protect soft tissues in the oral cavity. Sympathetic stimulation of
submandibular and sublingual glands results in a low flow rate of fluid containing a high
protein concentration (34).
Salivary protein secretion
Protein secretion is initiated by the binding of neurotransmitters to the
appropriate receptors on the basolateral membrane of acini secretory cells. The chief
neurotransmitter released by parasympathetic nerves is acetylcholine. Noradrenaline is
the primary neurotransmitter released by sympathetic nerves. Once bound, the
neurotransmitters signal the induction of downstream intracellular mechanisms,
beginning with second messengers and terminating in the release of salivary proteins
out of the acinar secretory vesicles and into the acinar lumen. The majority of salivary
gland protein excretion results from the exocytosis of protein storage granules in acinar
cells (31). The type of stimuli, including environmental and physiological factors, such
as: chemical or mechanical stimulation, psychological stress, pathological conditions
and pharmacological stimuli, alters the protein profile of the secretions (36). It is for this
reason that great attention is given to the types of stimuli enlisted for the collection of
saliva samples destined for analysis. In this study, to account for the variation in the
protein profile of the secretions caused by the factors listed above, samples were
carefully collected from individauls in the absense of chemical or mechanical stimulation
(unstimulated whole saliva). All individuals were maintained in a restful state before and
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during collection. Individuals must have met the inclusion criteria of being in a state of
good health and free of medications. These careful considerations helped to enable
appropriate comparisons between different age groups.
1.4

Composition of whole saliva

Since the beginning of salivary research in the early 20th century, saliva has been
recognized as a complex fluid. It has been stated that saliva is more appropriately
regarded as a fluid tissue than a solution (37).
Whole saliva originates from major (parotid, submandibular, sublingual) and
minor salivary gland secretions, as well as serum filtrate components (gingival
crevicular fluid), host cells derived from tissues throughout the oral cavity (desquamated
cells from the oral epithelium), microorganisms and microbial products (2, 5), blood and
serum products from wounds, nasal and bronchial secretions (19, 38-40), and food
debris (30). Plasma proteins are also present in saliva and are introduced through
several avenues. Passive diffusion, ultrafiltration (evident at tight cellular junctions) and
the contributions of serum transudate originating at the gingival sulcus referred to as
gingival crevicular fluid (GCF), are the most common modes of entry for plasma
proteins into saliva.
Water constitutes approximately 99.5% of the total volume of whole saliva (6, 7).
Proteins account for an estimated 0.3% of the total volume of whole saliva (6). Inorganic
and trace substances (i.e. electrolytes, sugars, lipids, hormones and nitrogenous
products) comprise the remaining 0.2% of whole saliva’s total volume. Inorganic and

11

trace substances, while relatively low in concentrations, are critical to saliva’s function in
the maintenance of oral health. Unstimulated saliva has an average pH range of 5.77.1, while stimulated saliva is known to have a pH of up to 7.8 (3).
Electrolytes present in saliva include: sodium, potassium, calcium, chloride,
magnesium and bicarbonate. These common electrolytes are present in final
concentrations that deem saliva hypotonic to other body fluids. Nitrogenous products,
such as urea and ammonia, are also present in saliva (1, 6, 7, 41).
Saliva

contains

an

estimated

700

species

of

microorganisms

(42).

Microorganisms contribute an assortment of enzymes to saliva’s composition (43).
Proteolytic enzymes, from multiple sources (i.e. bacterial, burst leucocytes), cleave a
great number of salivary proteins into peptides. The extensive proteolysis and
deglycosylation evident in saliva is another important consideration for salivary
research. Some proteins may be granted protection from proteolytic cleavage if bound
to hydroxyapatite, the primary constituent of tooth enamel. Histatin 1 is a good example
of a protein that avoids proteolytic cleavage by binding to the tooth surface (44).
Host-derived proteins present in saliva are commonly divided into structurally
related groups, referred to as salivary protein families. The major salivary protein
families are described in the next section.

12

1.5

Salivary protein families

The eight major salivary protein families are: Amylases, Histatins, Mucins,
Statherins, Cystatins, Carbonic Anhydrases, Peroxidases, and Proline-rich proteins.
Table 1.1 summarizes the primary protein source, chief known function, molecular
weight, modifications/isoforms if present, and concentration measured in whole saliva. It
is important to note that concentrations of salivary proteins vary, and the numbers
provided are mean values or ranges measured in resting whole saliva in adults.

Table 1.1 - Summary of Protein Families found in Saliva. The source, function, molecular weight, modification/isoforms and
concentration in whole saliva for the eight major protein families (Amylase, Histatins, Mucins, Statherins, Cystatins, Carbonic
Anhydrases, Peroxidases, and Proline-rich Proteins) are highlighted in this table.

Protein

Source

Amylase

Chiefly the
parotid gland

Histatins

Major salivary
glands (parotid,
submandibular
and sublingual)
and minor
salivary glands
(sublingual)

(17, 22,
45-47)

(17, 4850)

(1,
7, 17, 5156)
Mucins

Submandibular,
sublingual
glands
Primarily
sublingual and
minor mucous
glands

Statherins

(17, 55)

Produced by
acinar cells

Function

MW

Modifications/Isoforms

Digestion – Hydrolyzes starches (i.e. amylose,
amylopectin, maltose, glucose) by catalyzing hydrolysis
of alpha 1-4 glycosidic linkages in starch.
Protection – Selective binding of oral microorganisms
(i.e. S. gordonii, S. minits, S. oralis), preventing bacterial
attachment and aiding bacterial clearance.
Short distinct functional domains determine histains’
biological functions.
Anti-fungal: Kills C. albicans (in both yeast and mycelial
form) through the proposed mechanism of taking on a
helical structure that disturbs cell membranes. Histatins
are also potent C. albicans growth inhibitors
Anti-bacterial: Inhibits the trypsin-like activity of P.
gingivalis (gram negative bacteria associated with forms
of periodontal disease). Does not inhibit host trypsin or
chymotrypsin activity. Inhibits bacterial-induced
hemagglutination, and bacterial colonization.
Histatins also bind hydroxyapatite, complex with metal
ions, inhibit crystal growth of calcium phosphate salts
and stimulate wound-closure
Histatin 1 - protects tooth enamel and pellicle formation
(typical of phosphorylated salivary proteins)
Histain 5 – most potent candidacidal property amongst
histatins
Provides salivary viscoelasticity and lubrication.
Protection – physical barrier from bacterial protease
activity, helps regulate bacterial and fungal colonization
by selectively modulating adhesion of microorganisms to
oral tissue surface, lubrication, preventing desiccation
Concentrates anti-microbial salivary components to
mucosal interface
Helps form acquired enamel pellicle

53-57 kDa

Glycosylated and
unglycosylated isoforms
present

3-6 kDa

Histatins exist in 3 major
isoforms (Histatin 1, 3, and 5)
Histain 1, the only
phosphorylated isoform, is
phosphorylated on serine 2

Inhibits crystal growth of calcium phosphate salts
Inhibit the spontaneous precipitation of calcium
phosphate salts from the supersaturated concentrations
present in saliva.
Binds bacteria
Binds with high selectivity and great affinity to
hydroxyapatite

5380 Da

Conc. in whole
saliva
380-500
µg/mL

2-8 µg/mL

Major forms of histatin
undergo proteolytic cleavage
to form minor forms of histatin

120-1000
kDa
(Glycosylaton
account for
40-80% of
mass)

Two structurally distinct
species of mucins secreted
by salivary glands – MG1
(oligomeric) and MG2
(monomeric)
Glycosylation –high
carbohydrate content largely
on serine and threonine
residues
Phosphoproteins rich in
tyrosine, glutamine, and
proline

10-500 µg/mL

2-12 µg/mL

Cystatins

(17, 55)
Carbonic
Anhydrases

(17, 57)

Peroxidases

(58-61)

Proline-rich
protieins

(43, 55,
62)

Isolated from
submandibular
secretions
Submandibular
and parotid
glands
GCF and
neutrophil
granulocytes
(Myeloperoxidase), Salivary
glands
(Lactoperoxidase)

Bind hydroxyapatite (3 times weaker than statherin)
Inhibit crystal growth of calcium phosphate salts (10
times weaker than statherin)
Protection – involved in salivary pH regulation
Low salivary concentrations of CA-VI are associated
with increased prevalence of caries
Anti-bacterial action –Involved in the intracellular
metabolism of H2O2 leading to production of
hypothiocyanite (OSCN-) an even more effective
bactericidal and fungicidal agent. Helps prevent
decalcification of enamel caused by bacterial acid
production resulting from carbohydrate fermentation.
Solubilize calcium phosphate to inhibit crystal growth.
Remineralization – in the early and late acquired enamel
pellicle through the binding of hydroxyapatite (acidic
PRPs).
Caries prevention – a subset of basic PRPs differs in
individuals with resistance to caries formation.

14 kDa
42 kDa

78-280 kDa

SN, S, and S1 isoforms. Exist
in phosphorylated and
unphosphorylated forms.
7 isozymes and several
homologous carbonic
anhydrase-related proteins
Can be glycosylated

240-280
µg/mL

2 major forms found in saliva
- Myeloperoxidase and
Lactoperoxidase

1-5 µg/mL

PRPs are classified as
acidic, basic and glycosylated

4.6 µg/mL
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1.6

Functions of saliva

Saliva plays important roles in the mouth and upper portion of the gastrointestinal
tract that are critical for preserving health and homeostasis in the body. Saliva’s
functions, related to its fluid characteristics and composition, can be classified in the
following 5 broad categories:

Protection/maintenance of teeth and oral mucosa,

digestion, swallowing/clearance, airflow/speech, and taste.
1.6.1 Protection and maintenance of teeth and oral mucosa
Protection through lubrication
Lubrication, defined as the ability of a substance to decrease friction between
moving surfaces, is regarded as one of the most vital functions of saliva. Saliva
lubricates the mucosa and helps protect against irritation (i.e. mechanical, thermal, and
chemical) (7, 30, 31). The importance of appropriate lubrication is readily observed in
the effects of abrasive wear of epithelial surfaces and the destruction of tooth tissue
when sufficient lubrication is not present (6). Lubrication has been associated with
several salivary proteins, including: mucins (53, 63), statherin (63, 64), amylase (65),
proline-rich glycoproteins (3, 66), and acidic proline-rich proteins (63).
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Protection through immunological defense
Saliva is the first line of oral immune defense (67). The immunological defense
provided by saliva is of great importance, as the oral cavity serves as the entry point of
a wide range of substances into the alimentary track. This first line of defense protects
through anti-bacterial, anti-fungal and anti-viral functions. Anti-bacterial functions
include specific (i.e. secretory immunoglobulin A) and non-specific mechanisms (i.e.
lysozyme, lactoferrin, myeloperoxidase, cystatins, histatins, Von Ebner’s gland protein
(VEGh), secretory leukocyte protease inhibitor (SLPI), calprotectin, lactoperoxidase,
chromogranin A). Anti-fungal and anti-viral properties are similarly achieved with a
combination of specific (i.e. secretory immunoglobulin) and non-specific components
(anti-fungal: histatins, chromogranin A; antiviral: cystatins, mucins, SLPI). Mechanical
cleansing of bacteria and the dilution of detrius add to the immunological protective
functions of saliva.
Protection through buffering
Buffering and acid neutralization from oral and gastric sources is also conferred
by saliva’s composition, namely: bicarbonate, phosphate, and the negatively charged
residues in salivary proteins. The neutralization of acids produced by acidogenic
microorganisms offers teeth protection by preventing enamel demineralization (30). The
salivary peptide, sialin, is a good example of saliva’s buffering activity. Sialin increases
the pH on the tooth surface and releases ammonia and carbon dioxide after undergoing
hydrolysis by bacterial ureases (3, 41). The carbonic acid-bicarbonate system serves as
an excellent example of an important pH buffer in stimulated saliva and phosphate
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buffer in unstimulated saliva (3). In saliva, hydronium and bicaronate ions combine to
form carbonic acid. Carbonic anhydrase functions to regulate pH by facilitating the
conversion of carbonic acid into water and carbon dioxide. Through the actions of
bicarbonate ions working in concert with carbonic anhydrase, the pH is effectively
increased through the net eilmation of hydronium and bicarbonate ions and production
of water and carbon dioxide.
Maintenance of teeth and oral mucosa
Saliva occupies a vital role in maintaining the physical-chemical integrity of tooth
enamel. In addition to lubrication of the hard and soft tissues and buffering capacity of
saliva, the maintenance of the integrity of teeth and oral mucosa is achieved through
saliva’s ability to protect against demineralization (mucins, Ca2+, phosphate), and
recuperate mineral loss through remineralization (PRPs, statherin, Ca2+, phosphate)
(31).
The stability of tooth enamel’s hydroxyapatite composition is controlled by
salivary pH and concentrations of free calcium, phosphate and fluoride. The
supersaturated calcium phosphate concentration, with respect to hydroxyapatite, leads
to the formation and maintenance of the protective pellicle present on the enamel
surface. Maintaining the equilibrium between calcium phosphate demineralization and
remineraliztion is a critical function of salivary proteins (55).
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1.6.2 Digestion
Saliva is also responsible for the initiation of starch and lipid digestion. Digestive
enzymes, such as alpha-amylase, cleave starches into maltose, maltotriose, and
dextrins, contributing to the digestive process (30).
1.6.3 Swallowing/Clearance
Saliva dilutes and mechanically cleanses non-adherent particles (i.e. bacteria,
cellular, and food detritus), aiding in their clearance from the oral cavity. As an added
benefit, the clearance of food detritus, in particular excess carbohydrates, results in a
reduction of the availability of sugar for microorganism metabolism (7). Food bolus
formation aiding swallowing is also helped by the presence of saliva (30). By extension,
the clearing capabilities of saliva are not limited to the oral cavity, as it also aids
esophageal clearance.
1.6.4 Airflow/Speech
The fluid properties of saliva are critical to facilitate airflow and enhance speech
quality. The importance of this function is most evident in instances with reduced
salivary flow.
1.6.5 Taste
By serving as a solvent, saliva also facilitates taste by aiding in dissolving taste
compounds and enhancing interaction of food products with taste buds (30). While the
salivary fluid in acini starts isotonic to plasma, as it travels through the duct network it
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becomes hypotonic in glucose, sodium, chloride and urea concentrations (3, 34). This
aids in the perception of dissolved substances by gustatory buds.
1.6.6 Conclusion to functions of saliva
With such vital functions, saliva is of monumental importance in the maintenance
of teeth, oral mucosa and overall oral health (3). While the functions of a great number
of proteins and peptides contained in saliva are not yet well understood, it is clear there
is a great deal of redundancy in salivary composition for it to be able to accomplish
these functions and uphold the integrity of the teeth and oral mucosa with the required
ecological balance (3, 31).
1.7

Current Knowledge of the salivary proteome

Proteomic studies centered on identifying the salivary proteome have increased
dramatically in the past decade. The investigation of proteins on a large scale draws
upon an ever-improving toolbox of techniques (13, 24, 28, 68-77).
During the past decade, more than 3000 different proteins have been identified in
saliva (15, 18, 24, 25, 75, 78, 79). In 2010, Loo and colleagues from the University of
California-Los Angeles compiled recent data from multiple laboratories to form a list of
2290 proteins present in whole saliva (72). Most recently, the same laboratory identified
1,166 proteins as the core salivary proteome (80). This compiled data set was consulted
during the analysis of proteins in this study. The ongoing fluctuation in the size of the
salivary proteome catalogue is closely related to the challenges present in the analysis
and categorization of salivary proteins. One of those challenges is the great number of
structurally related proteins found in saliva. The abundance of structurally related
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proteins is commonly shared with other proteomes, most notably in blood, and has
important implications with the application of mass spectrometric-based methods for the
identification of proteins. Protein identification with MS/MS relies on sequencing
peptides unique to a protein. If a sequenced peptide is common between a number of
proteins, the accurate identification of the parent protein becomes more difficult. To
address this, a variety of proteomic tools are often enlisted to accurately distinguish
unique protein species.
The critical stage of any study examining proteins in a complex mixture is protein
separation. A wide variety of protein separation techniques have been applied to the
study of salivary proteins. Gel electrophoresis and liquid chromatography are two of the
most powerful protein separation techniques applied in salivary studies.
Both 1- and 2-dimensional PAGE (1D- and 2D-PAGE) are effective methods of
protein separation and have been widely used to separate salivary proteins (4, 6, 14,
29, 81). Both methods provide visuals of profiles of protein mixtures that can be used to
assess variability between samples, people, and groups. 2D-PAGE is a powerful
technique of protein separation but harbors significant limitations that remain highly
relevant in salivary protein research. 2D-PAGE is ill suited for the detection of small MW
proteins, highly acidic or basic proteins, highly hydrophobic proteins, as well as proteins
in low abundance (6). The presence of many small MW proteins and peptides, as well
as a significant number of highly acidic, basic, hydrophobic and proteins present in very
low concentrations in saliva, invites alternative methods of protein separation, such as
liquid chromatography.
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1.8

Purpose of thesis

With a great impetus to realize the tremendous translational potential of saliva as
a diagnostic resource, the focus must now be concentrated on developing and
understanding the basic biochemistry of saliva at all stages of life. The successful and
meaningful analysis of salivary proteins necessitates optimized methods of collection,
processing and storage conditions (82).
Until now, the majority of proteomic studies have focused on adult populations,
with very little attention given to characterizing the salivary proteome in children.
Clinically, it is known that children and adults differ in an array of biological parameters
used to assess health status via monitoring and diagnostic tools. Saliva, as well as
blood, have both been shown to harbour clinically relevant age-dependent differences.
While the focus of this study is not centered around gender, race, or environtmentallyrelated differences, these are also factors that warrant continued attention as they may
provide further valuable biological insights. It is imperative to understand the standard
baseline of the salivary protein profile, and how it changes with age, among other
factors, in order to establish appropriate comparisons between individuals at different
states of health.
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With this knowledge, the purpose of this thesis is centered on the following two
central aims:
1. To establish and optimize techniques for the analysis of the salivary proteome in
children, as well as adults. Establishing techniques and optimizing methods is a crucial
step in the successful and meaningful analysis of salivary samples.
2. To identify qualitative and quantitative changes in salivary protein profiles as primary
dental eruption events unfold in children from the ages of 0 to 3 years.
1.9

Hypothesis

We hypothesize that there are observable qualitative and quantitative changes in
the salivary protein profile throughout the course of dental eruption, in children from age
0 to 3 years.
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Chapter 2 – Changes in the salivary proteome during the course of dental
eruption
2
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2.1

Experimental Design Overview

2.1.1 Sample Collection
The eligibility of individuals to donate unstimulated whole saliva for this study was
based on the following inclusion criteria. The individual must be deemed healthy
according to their medical history, and therefore free of any acute or chronic medical
conditions (i.e. Asthma, diabetes, renal or cardiac conditions). At the time of sampling,
the individual must be included in one of the following four categories:
Children with no teeth – Absence of primary dentition
Children with 1-19 primary teeth – Partial primary dentition
Children with 20 primary teeth – Complete primary dentition
Adults with 0 permanent teeth – Complete denture patients

Samples were rejected from this study if any of the “Exclusion Criteria” in Table
2.2 were met. Individuals must not be taking any medication to avoid potential drugrelated effects on salivary flow and/or composition. Collection of unstimulated whole
saliva from individuals meeting the “Inclusion Criteria” listed in Table 2.2 was sampled in
the described manner.
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Table 2.1 - Summary of group categories. Groups A, B, and C represent children participants pre-,
during, and post-dental eruption, respectively. The age ranges described in the table for Groups
A, B, and C, serve only as guidelines. Samples from children were grouped according to the
number of teeth present at the time of collection. Group D represents the edentulous adult
controls.
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No. of
Teeth

Group
Children

Adults

A

Pre-dental eruption

B

During dental eruption

C

Post-dental eruption

D

No dentition (edentulous)

Description
0

1-19
20
0

Children approx. 0-6 months old*
Children approx. 7-24 months old*
Children approx. 25-36 months old*
Adults <65 years of age with complete dentures

*Age categories serve only as guidelines indicating the stage of dental eruption. Samples were classified strictly based on the
number of teeth full and partially erupted at time of collection.
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Table 2.2 - Criteria used in the selection of individuals to donate saliva. All individuals included in
this study were required to meet the inclusion criteria. Salivary samples were excluded from the
analysis if any of the exclusion criteria were met.
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Inclusion Criteria

Exclusion Criteria

Healthy – including their medical history

Presence of any chronic or acute medical conditions

Children approx. 36 months or younger

Consumption of any food or water within 1 hour prior to collection

OR

Edentulous adults 65 years or younger

If individual became stressed during collection
Any medications (as they may interfere with salivary secretion and
composition)
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All saliva samples were collected between the hours of 10:00 AM and 12:00 PM,
to minimize any inter-individual variation of saliva composition associated with circadian
rhythms (83). Unstimulated whole saliva was aspirated using a portable suction device
and disposable mouthpiece attached to a 1.5 mL eppendorf snap cap tube, as depicted
in the schematic in Figure 2.1. To prevent proteolytic degradation of salivary proteins,
collection tubes remained on ice at all times during collection. To achieve an accurate
assessment of resting, unstimulated whole saliva, great care was put forth during
collection to ensure the individual was seated comfortably while collection took place.
Sample was discarded if subject became stressed or if child began to cry. Upon
completion of sample collection, all samples were stored at – 40°C.
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Figure 2.1 - Schematic of suction device adapted for collection of unstimulated whole saliva
samples. The portable suction device, shown on the left of the schematic, produced a gently
powered suction that was connected to the eppendorf snap cap lid with a needle adaptor. A
second needle adaptor attached to a disposable mouthpiece and tubing was inserted to the same
eppendorf snap cap tube, as depicted in the figure. This set up resulted in a disposable
mouthpiece terminal with gentle but effective suction, well suited to collect whole saliva from
children and adults. All collection tubes remained on ice during the collection process.
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2.1.2 Patient Demographics
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Table 2.3- A summary of the unstimulated whole saliva samples collected for this study. The
following patient demographic parameters from all four groups, Group A (Pre-dental eruption),
Group B (During dental eruption), Group C (Post-dental eruption), and Group D (Adult controls)
are summarized: Age, sex, volume of unstimulated whole saliva collected, and number of teeth
present.
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2.1.3 Project Experimental Design
The goal of this study was to examine and compare the salivary proteome in
children during the course of dental eruption in children and edentulous adult controls.
Hence, children were divided into three cohorts (pre-, during, and post-dental eruption)
and adult controls grouped into a fourth cohort. Samples were analysed individually, as
well as pooled in each cohort, to assess both inter-individual and inter-group
differences. The overall design of the experimental approach used in the analysis is
shown in Figure 2.2. The scheme describes the analysis flow for all samples.
Whole saliva samples were centrifuged and the supernatants collected. The
supernatants were then quantified for total protein concentration. The supernatants
were then used to complete the three major avenues of analysis seen in Figure 2.2,
PAGE, HPLC and MS. Separation of proteins based on molecular weight, negative and
positive charge was achieved using PAGE. The minimal protein requirement for PAGE
analysis permitted the analysis of pooled cohort samples in both gel types (SDS and
anionic) and individual samples to be examined with both SDS and anionic PAGE.
Separation as a function of the degree of protein hydrophobicity was realized through
the use of reverse phase HPLC. Protein identification was attained through mass
spectrometric analysis. Processing and analysis of all whole saliva samples used in this
study was completed according to the following methodologies.
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Figure 2.2 - The overall experimental design for the analysis of unstimulated whole saliva
samples. The first stage of the experimental design involved recruiting children pre-, during, and
post-dental eruption (Groups A, B, and C, respectively), as well as edentulous adult controls
(Group D) to participate in the study. Saliva sample collection was followed by total protein
quantification. The samples were then analyzed first with PAGE, followed by HPLC, and then LCMS, as described in the methods.
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2.2

Materials and method

Due to the mixture of components present in whole saliva, in particular proteolytic
enzymes and mucins, precautions are taken and all procedures adhered to with respect
to sample collection, processing prior to analysis, sample storage and treatment, to
ensure the successful preservation and analysis of all samples.
2.2.1 Unstimulated whole saliva collection
All samples were collected from study participants with full consent and approval
(See APPENDIX 2 for General Letter of Information and Consent). The collection
protocol was approved by the Health Sciences Research Ethics Board (HSREB) at
Western. Parents or Legal Guardians were consulted for sample collection from child
participants. All sampling was conducted between a two-hour period (10:00 AM and
12:00 PM) to minimize inter-individual variation of saliva composition associated with
circadian rhythms

(83). To ensure true resting and unstimulated saliva samples,

participants did not consume any food or water for a full hour prior to collection. All
participants were relaxed and seated upright throughout collection. At the first signs of
distress, most relevant for the youngest volunteers, collection was stopped and samples
discarded. This procedure ensured all samples reflected resting unstimulated whole
saliva. Samples were collected with a sterile disposable mouthpiece connected to a 1.5
mL polypropylene microtube. A portable suction device was used to create a gentle
suction in the tube to facilitate saliva collection. See Figure 2.1 for an illustration of the
set-up successfully adapted for the collection of unstimulated whole saliva. Throughout
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sampling, collection tubes were stored on ice to inhibit proteolytic degradation of
salivary proteins outside the oral cavity.
2.2.2 Pre-analysis sample processing
Immediately after collection saliva samples were centrifuged at 14 000 rpm for 20 min at
4°C. The supernatants were gently aspirated with a 200 µL pipette to avoid disturbing
the pellet. The supernatants were aliquoted into microfuge tubes and frozen at -40°C.
Prior to analysis, aliquots were thawed on ice.
2.2.3 Total protein quantification
The most suitable method for quantifying total protein concentration in whole
saliva samples was determined by comparing the Bradford Protein Assay Kit (Thermo
Scientific, Rockford, IL) and the Pierce BCA Protein Assay kit (Thermo Scientific,
Rockford, IL) for sensitivity and reproducibility. The Pierce BCA Protein Assay proved to
be the most appropriate and was used to analyze all saliva samples.
2.2.4 Protein separation via polyacrylamide gel electrophoresis
Polyacrylamide gels were used in two modes (SDS and Anionic native) to
separate proteins based on size and negative charge, respectively. Each sample was
run individually to assess inter-individual variability in protein pattern. In addition,
samples were pooled and run according to their group to identify inter-group variability.
Polyacrylamide gels (8.3 X 7.3 cm X 0.1 cm, 10% acrylamide) were cast in a
MiniPROTEAN® IV system (Bio-Rad, Hercules, California). The gels were pre-run at 30
V for 30 minutes immediately prior to sample loading. SDS gels were loaded with 20 µg
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of total protein, while Anionic gels required 100 µg of total protein to allow for sufficient
protein separation and band visualization. The Anionic gels required a larger quantity of
total protein to be loaded because this gel type separates only negatively charged
species, unlike SDS gels which are able to separate proteins regardless of their charge.
Negatively charged proteins constitute a fraction of the total proteins present in saliva,
thus requiring more total protein loading in Anionic gels to provide sufficient quantities
for visualization. Samples run on SDS-PAGE were placed in boiling water for 5 min and
allowed to cool to room temperature prior to loading. While SDS is an effective
denaturing agent, heating the samples further enhances the action of SDS by further
disrupting protein structure. The gels were stacked and run at a constant voltage of 100
V in a MiniPROTEAN® Tetra Cell (Bio-Rad, Hercules, California) for 1.5-2 h, or until the
dye front had migrated to approximately 0.5 cm from the bottom edge of the gel.
2.2.5 Gel imaging, image analysis and band quantification
Coomassie Brilliant Blue and silver staining were tested for their suitability as a
staining option for both SDS and Anionic PAGE gels. Coomassie and silver have
detection limits of approximately 100 ng, and 1 ng, respectively (84). While silver
staining has a much lower limit of detection, the narrow linear dynamic range, relative to
Coomassie makes this staining method less suitable for quantification (84-86). Due to
the importance of quantifying the protein profile in the gels, Coomassie was selected for
use in this study over silver staining. All gels were stained with the colorimetric stain
Coomassie Brilliant Blue (Thermo Scientific, Rockland, Illinois). To minimize
background staining, destaining was achieved by incubating gels for 2 hours with
destaining solution (40% Methanol, 10% Acetic Acid in milliQ dd H2O) under gentle
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agitation, followed by 3 washes with milliQ ddH2O. Gel image acquisition was achieved
using an Epson Perfection 4990 Photo scanner at the Best Scanning Quality, with 24-bit
colour and 400 dpi. The scanned gels were analysed using TotalLab Quant v12.5. Band
intensity was quantified and the gel-specific background subtracted to normalize
intensity data.
2.2.6 Protein separation via high performance liquid chromatography
A reversed phase C4 column was chosen (XBridge™ BEH300 C4 3.5 µm, 4.6
mm X 150 mm, Waters) to separate the complex mixture of whole proteins based on
degree of hydrophobicity. To equally represent every individual from each group,
equivalent amounts of protein were pooled for each run. Pooled protein samples
containing 100 µg of total protein from each group were diluted with 0.1% TFA to reach
a total volume of 1 mL. Pooled samples were syringe filter sterilized using a 0.2 µm
Supor® Membrane (PN 4602, Pall Corporation, Ville St. Laurent Quebec) with a 1mL
syringe (Reference number: 329650, Franklin Lakes, New Jersey). Immediately after
filtration, samples were injected onto the equilibrated C4 column following a full blank
method run to confirm the absence of carryover between samples. The method was
initialized with 100% Buffer A (0.1% TFA in milliQ dd H2O) and gradually increased
Buffer B (ACN + 0.1% TFA in milliQ dd H2O) concentrations until a final concentration of
55% acetonitrile was reached with a 110 min method. A dual UV/Visible detector
(Model: 2489, Waters) allowed for the simultaneous measurement of absorbance at 214
nm and 280 nm to visualize both peptide and protein profile patterns across all groups.
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2.2.7 Sample preparation for mass spectrometric analysis
Due to the vast range of total protein concentrations determined in the samples,
utilizing a protocol with a standardized volume would have resulted in a drastic overrepresentation of samples with a high protein concentration, and an underrepresentation of samples with a low protein concentration. Therefore, standardized
weight was selected, rather than volume of saliva supernatant, to provide each
individual with equal protein representation in the MS analysis. A total of 5 µg of total
protein from each individual was combined in each pooled group sample. Low-protein
binding 0.5 ml polypropylene microtube and low-protein binding tips were enlisted in
every step of MS sample preparation to minimize protein loss prior to analysis. Pooled
samples were aliquoted and immediately processed, or frozen at – 40°C.

Aliquots

containing 15 µg of pooled total protein from each group were prepared as follows for
LC MS/MS analysis. The final volume of each tube was brought to 50 µL with 4 M Urea,
10 mM DTT, 50 mM NH4HCO3, pH 8.0) and incubated for 1 hour at room temperature
(~25°C) to denature and reduce samples. Samples were then diluted 4-fold with 50 mM
NH4HCO3, pH 8.0. Mass Spectrometry grade Trypsin was added 5% w/w (Promega)
followed by incubation at 37°C for 16 h to complete proteolytic digestion. Samples were
dried with an Eppendorf VacufugeTM.
2.2.8 Mass spectrometric analysis
Prior to analysis, samples were cleaned with a C18-ZipTip (Millipore, Watford,
United Kingdom) to eliminate accumulated salts and denaturants (i.e. Urea) and
optimize signal-to-noise ratio on spectra. Analyses were performed using liquid

44
chromatography with an Agilent 1100 Capillary LC system (Palo Alto, California) in-line
with a linear ion trap quadrupole tandem mass spectrometer (Thermo Electron, San
Jose, California). Digested proteins were separated with a C18 pre-column consisting of
polyimide-coated fused silica capillary column (100 µm internal diameter X 5.0 cm
length) (InnovaQuartz, Phoenix, Arizona) and a micro-liquid chromatography analytical
column (75 µm X 10 cm) (Proxeon Biosystems, Odense, Denmark) with C18 resin (5
µm diameter bead, 200 Å pore) (Varian, Palo Alto, California) that also functioned as a
microelectrospray emitter. The reverse phase chromatography was achieved with an 80
minute gradient elution from optima grade water to acetonitrile (Fisher Scientific,
Ottawa, Ontario) each containing 0.1% formic acid (FA) (VWR, Mississauga, Ontario)
and 0.2% protein sequencing grade trifluoroacetic acid (TFA) (Sigma-Aldrich, Oakville,
Ontario) with an injection volume of 5 µL and a flow of 200 nL/min. The mass
spectrometer was operated in data-dependent acquisition mode cycling automatically
through acquisition of full-scan mass spectrum and three MS/MS spectra sequentially
on the three most abundant ions present in the initial MS scan. All samples were run in
duplicate with identical experimental parameters.

45
2.2.9 Searching the data base
All MS/MS samples were analyzed using Mascot (version 2.2, Matrix Science,
London, United Kingdom) and X! Tandem (version 2007.01.01.1). The samples were
searched against the NCBInr database assuming trypsin digestion. Mascot and X!
Tandem were searched with a fragment ion mass tolerance of 0.05 Da and a parent ion
tolerance of 3.0 Da. In Mascot, variable modifications were specified as follows:
Oxidation of methionine, deamination of asparagine, deamination of unknown,
acetylation and carbamylation of the n-terminus. No fixed modifications were specified.
Scaffold (version Scaffold_2_06_02, Proteome Software Inc., Portland, Oregon)
was enlisted to validate MS/MS based peptide and protein identifications. Peptide
identifications with a greater than 95.0% probability were accepted

(87). Protein

identifications with a greater than 95.0% probability, as well as a minimum of 1 identified
peptide, were assigned by the Protein Prophet algorithm (88).
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2.3

Results

2.3.1 Comparison of total protein quantification methods
Two protein quantification methods, Bradford and bicinchoninic acid (BCA)
assay, were compared to determine the most suitable technique for total protein
quantification of unstimulated whole saliva samples. Both methods are widely used to
quantify protein concentrations in proteomic studies.
The BCA assay is similar to the Lowry method, with the added advantage of
increased sensitivity. It relies on protein forming complexes with Cu2+ under alkaline
conditions followed by the release of Cu+ from the reduction of the copper-protein
complexes, leading to a colorimetric change. The amount of protein present determines
the amount of reduction and resulting quantifiable colour modification. This method
measures the amount of cysteine, cystine, tryptophan, tyrosine and peptide bonds, all of
which are capable of reducing Cu2+ to Cu+. When measured at 592 nm, the linear
working range of the BCA assay reaches 2,000 µg/ml, well above the average total
protein concentration of whole saliva of approximately 1,000 µg/ml.
The Bradford assay has the advantage of working very quickly and requiring
small amount of sample. Minimizing the amount of limited biological sample required is
of great importance. However, the assay sensitivity is poor, relative to the BCA assay.
The Bradford method uses Coomassie Brilliant Blue dye to bind protein through
hydrophobic and ionic interactions. The anionic form of the dye is stabilized through this
protein binding, resulting in a colour change detected at 595 nm. The linear working
range of the Bradford assay is limited to at or below 1,000 µg/ml.
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The most suitable protein quantification assays are those in which the properties
being measured are equally distributed within all samples. The BCA assay’s detection
of peptides bonds and four amino acids in salivary samples is much more
representative of the total protein concentration than the less uniformly distributed
hydrophobic and ionic interactions detected by the Bradford method.
Ultimately, due to the requirement of a larger linear working range, heightened
sensitivity, and a reliable total protein concentration measurement for each sample, the
BCA assay was selected, a stable, reliable, reproducible method, appropriate for protein
concentrations from 20-2,000 µg/ml. Bovine serum albumin, a common protein standard
used in salivary proteomic studies, was selected as protein standard for the total protein
quantification assays.
2.3.2 Total protein quantification
All saliva samples collected from 44 individuals from 4 groups (Group A: Children
pre-dental eruption (no teeth), Group B: Children during dental eruption (partial primary
dentition), Group C: Children post-dental eruption (complete primary dentition), Group
D: Adults edentulous (complete denture patients)) were subject to total protein
concentration quantification using the BCA assay. The results are summarized in Table
2.4.
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Table 2.4 Summary of total protein concentration in collected saliva samples from all four groups,
Group A (pre-dental eruption), B (during dental eruption), C (post-dental eruption), and D (adult
controls) as measured with the BCA assay. The individuals ranged in age from 2 wks – 61.75
years of age.
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Clinical Parameters with Total Protein Concentration
GROUP A –Children –pre-dental eruption
Age (# of months)
Sex
Protein concentration [µg/mL]
508.64
A001
7.00
F
585.00
A002
2.75
M
1205.63
A003
0.75
M
886.18
A004
5.75
M
235.45
A005
6.50
M
379.27
A006
6.75
F
506.36
A007
6.50
M
1679.27
A008
2.75
M
745.81
A009
4.25
F.
522.00
A010
5.50
F
854.18
A011
4.75
F
284.73
A012
2.75
F
GROUP B –Children –during dental eruption (Partial Primary Dentition)
Age (# of months)
Sex
Protein concentration [µg/mL]
580.27
B001
6.50
F
346.73
B002
6.25
M
972.82
B003
12.25
M
704.55
B004
23.00
M
448.55
B005
16.00
M
3207.27
B006
15.25
F
967.27
B007
19.25
M
463.09
B008
9.75
F
689.64
B009
19.75
M
833.45
B010
14.00
M
GROUP C –Children – post dental eruption (Complete Primary Dentition)
Age (# of months)
Sex
Protein concentration [µg/mL]
1084.18
C001
35.50
F
821.09
C002
39.25
F
957.18
C003
42.00
M
797.64
C004
23.50
F
1362.73
C005
41.75
M
932.49
C006
38.00
M
751.55
C007
31.50
M
1280.36
C008
37.75
M
1484.18
C009
29.00
M
1003.09
C010
31.00
F
495.64
C011
31.75
M
1260.36
C012
29.00
M
GROUP D –Adults – edentulous (Complete Denture Patients)
Age (# yrs)
Sex
Protein concentration [µg/mL]
1421.94
D004 (1)
58.83
F
826.90
D005 (2)
44.50
F
1583.16
D006 (3)
47.08
F
852.26
D008 (4)
49.75
M
848.64
D009 (5)
61.75
F
969.09
D010 (6)
37.58
F
2074.05
D011 (7)
35.00
M
1393.87
D012 (8)
55.08
M
5398.86
D013 (9)
52.33
M
1181.09
D014 (10)
56.00
M

Teeth erupted (#)
0
0
0
0
0
0
0
0
0
0
0
0
Teeth erupted (#)
4
1
7
16
2
6
14
6
16
8
Teeth erupted (#)
20
20
20
20
20
20
20
20
20
20
20
20
Teeth present (#)
0
0
0
0
0
0
0
0
0
0
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2.3.3 Statistical analyses of clinical data
In order to identify any significant trends or differences in the clinical data, a
statistical analysis was enlisted. The clinical parameters of age, sex, number of teeth
present, and protein concentration in collected saliva samples were subjected to
analysis. The nonparametric nature of the collected data was examined with the
Kruskal-Wallis, the Mann-Whitney U Test, and Spearman’s analysis. SPSS statistics
was the software chosen to complete the statistical analysis of the clinical data.
Statisticians regard SPSS as the gold standard software for statistical analyses.
The Kruskal-Wallis hypothesis test is a nonparametric one-way analysis of
variance. It is useful in the comparison of more than two independent samples. A
significant result from a Kruskal-Wallis test states that a minimum of one of the samples
is different from the other samples. The Kruskal-Wallis hypothesis test determined that
the distribution of the protein concentration was the same across all four groups. The
Kruskal-Wallis test also determined that the distribution of the volume of saliva collected
was the same across all four groups.
The second nonparametric analysis enlisted was the Mann-Whitney U
hypothesis test. This test analyzes for significant differences between specific sample
pairs. The Mann-Whitney U hypothesis test works from a null hypothesis describing two
groups as the same opposed to an alternative hypothesis.
In accordance with the Kruskal-Wallis test, The Mann-Whitney U hypothesis test
also determined that the distribution of the volume of saliva collected was the same
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across all four groups. Both the Kruskal-Wallis test and the Mann-Whitney U test level
of significance were set at 0.05.
Spearman’s analysis, often referred to as Spearman’s rho, is the third
nonparametric test applied to this clinical data set. This analysis measures two
variables’ statistical dependence upon each other.
Spearman’s rho determined there was a significant correlation between age and
protein concentration in the collected samples, with a correlation coefficient of 0.48
(n=44) at the level of 0.01. A significant correlation was still seen when the males and
females were tested separately for correlations between age and protein concentration.
Males (n=26) and Females (n=18) had correlation coefficients of 0.635 at the level of
0.01 and 0.42 at the level of 0.05, respectively. Spearman’s analysis determined no
significant correlation between volume of saliva and protein concentration, volume of
saliva and age, and finally, protein concentration and teeth erupted.
Appendix 3 includes the tabulated results of the clinical data and statistical
analyses of the Kruskal-Wallis hypothesis test, the Mann-Whitney U hypothesis test,
and the Spearman’s analysis.
Making use of the measured total protein concentrations in this study, a future
sample size calculation was completed to inform the determination of sample sizes in
future studies. The calculated mean values of the youngest (Group A) and oldest
children (Group C), and their associated standard deviations were used, as they
represented the pre- and post-dental eruption populations, a primary focus of this
research. With clinical consultation determined a clinically relevant difference limit of
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200 µg/mL of total protein concentration between groups. A power of 0.80, and an alpha
of 0.05 were the standard values assigned to this calculation, representing an 80%
chance of detecting a clinically relevant difference when one is present, and a 5%
chance of detecting a clinically relevant difference when there is none. Using these
parameters, a future sample size is recommended to be 48 per group (n = 48), bringing
a study with four groups to a total study size of 192 (n = 192).
2.3.4 Protein separation via polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis was used to separate proteins based on
negative charge (Anionic-PAGE) and size (SDS-PAGE). Loading each lane of a gel with
a sample from a single individual allowed the assessment of intra-group variability, a
visual representation of differences between individuals of a single group. Inter-group
variability, the differences between groups, was assessed by pooling samples from
Group A and running the resultant pooled samples in a single lane alongside individual
lanes of pooled samples from Group B, C and D.
Protein profiles were quantified first using Photoshop followed by TotalLab Quant
v12.5. Photoshop allowed for pixel counts of individual bands, but was unable to take
into account the intensity of the stained protein. Band density can vary even within the
same gel. Therefore, using only a count of pixels and not intensity, large diffuse protein
bands were often overestimated, while small densely packed bands were largely
underestimated for the amount of protein they contain. In order to take band intensity
into proper account, to achieve a truly accurate measurement of protein quantity in all
cases, gels were re-analyzed and bands re-quantified using TotalLab Quant v12.5. With
the ability to consider band intensity as well as band surface area, TotalLab Quant
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v12.5 allowed for the quantification and comparison of protein profiles from all individual
and group samples successfully.
2.3.5 Anionic PAGE
The following section displays the anionic PAGE comparing pooled protein from
each of the four groups run alongside purified human serum albumin. The stacking gel
was maintained atop the separating gel to confirm the large amount of protein that was
unable to enter the separating gel to be separated and visualized in this manner. The
resultant band intensity quantification as measured by TotalLab Quant v12.5 is also
displayed in this section.
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Figure 2.3 - Anionic-PAGE Inter-group variability. Each lane represents protein pooled from all the
individuals in a single group (100 µg loaded in each lane). Gel was stained with Coomassie
Brilliant Blue. Lane indicated with an ‘X’ was loaded with 4 µg of human salivary protein standard human serum albumin (HSA). Lanes A, B, C, and D represent pooled samples from Groups A, B,
C, and D, respectively.
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Figure 2.4 - Inter-group variability visualization through band intensity quantification of anionicPAGE. Each line represents the relative intensity of stained salivary protein from each lane
consisting of pooled samples from all the individuals in a single group.
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2.3.6 SDS PAGE
The following section displays the SDS PAGE comparing individual saliva
samples run along a molecular weight standard ranging from 10-250 kDa. The stacking
gel was maintained atop the separating gel to confirm that the vast majority of proteins
were not retained at the interface between the stacking gel and the separating gel,
unlike the large amount of protein that was unable to enter the separating gel to be
separated and visualized in the anionic PAGE seen earlier. The resultant band intensity
quantification as measured by TotalLab Quant v12.5 is also displayed in this section.
Through the quantification of band intensities in the gel run with pooled saliva
samples from each group (Inter-group gel, Fig 2.10), and the summation of intensities
all the individual profiles seen in the intra-group gels (Fig. 2.5) a comparison of trends
can be drawn between the two methods (non-pooled intra-group gels, and pooled intergroup gels). A summary of this comparison is displayed in Figures 2.11 and 2.12.
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Figure 2.5 - SDS-PAGE Intra-group variability. A), B), C), and D) display results from Groups A, B,
C, and D respectively. Gels are seen here stained with Coomassie Brilliant Blue. Furthermost left
lane in each gel was loaded with a molecular weight marker, numbers indicating kilo Daltons
(kDa). Each lane to the right of the molecular weight marker represents 20 µg of total protein from
a single individual, therefore each lane represents a different individual.
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A)

B)

C)

D)

Figure 2.6 - Group A - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group A (Children predental eruption) from Figure 2.5 A.

Figure 2.7 - Group B - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group B (Children during
dental eruption) from Figure 2.5 B.

Figure 2.8 - Group C - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group C (Children postdental eruption) from Figure 2.5 C.

Figure 2.9 - Group D - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group D (Adult controls)
from Figure 2.5 D.
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Figure 2.10 - SDS-PAGE Inter-group variability. Each lane represents protein pooled from all the
individuals in a single group (20 µg loaded in each lane). Lanes A, B, C, and D represent all the
pooled samples from Group A (Children pre-dental eruptions), Group B (Children during dental
eruption), Group C (Children post dental eruption), and Group D (Adult controls), respectively. Gel
is seen here stained with Coomassie Brilliant Blue. Furthermost left lane was loaded with a
molecular weight marker, numbers indicating kilo Daltons (kDa).
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Figure 2.11 - SDS-PAGE Inter-group variability. Each line represents the quantified intensities of a
single lane visualized on the single gel displayed in Figure 2.10. Each lane of the gel represents
protein pooled from all the individuals in a single group. Lines A, B, C, and D represent all the
quantified band intensities of pooled samples from Group A (Children pre-dental eruptions),
Group B (Children during dental eruption), Group C (Children post dental eruption), and Group D
(Adult controls), respectively.
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Figure 2.12 -. SDS-PAGE Inter-group variability measured on the four separate gels displayed in
Figure 2.5 A, B, C, D, representing Group A (Children pre-dental eruptions), Group B (Children
during dental eruption), Group C (Children post dental eruption), and Group D (Adult controls).
Each line in this figure represents the quantified intensities summed across one of the four
separate gels seen in Figure 2.5. Lines A, B, C, and D represent all the quantified band intensities
across all the lanes in Figure 2.5A, B, C, and D, respectively.
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2.3.7 High performance liquid chromatography
High performance liquid chromatography (HPLC) was used in two capacities in
this study. The first application provided another avenue of protein separation and
independent visualization of the whole protein profiles present in saliva in all four
groups. The second application of HPLC was in-line with the mass spectrometer,
serving to separate trypsin digestion protein fragments immediately prior to mass
spectrometric analysis.
HPLC provides an excellent method of visualizing profiles of protein
mixtures, separating proteins based on a range of properties (i.e. hydrophobicity, net
charge, size/shape, metal binding etc.). In order to gain information about the whole
protein profile of each group, the HPLC was used to analyze whole protein (avoiding
tryptic-digestion) samples pooled from all individuals in each group. To add a unique
dimension of separation not previously achieved with the PAGE analysis (Anionic –
separated proteins based on their negative charge, SDS – separated proteins based on
their molecular weight), a reverse phase column has been selected separate based on
protein hydrophobicity. The column selected for sample analysis was a C4 XBridgeTM
column. After extensive method optimization, the column proved its ability to
reproducibly separate the complex protein mixture found in whole saliva, as well as
parotid saliva. Parotid saliva served as a less-complex protein mixture but with much in
common with whole saliva. Being far less complex in nature, the use of parotid saliva
reduced unnecessary loading on the column during the comprehensive optimization
process.
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Chromatograms indicating successful and reproducible protein profile acquisition
are displayed in Figures 2.13-2.16.
Once appropriate gradient range was established, flow rate and amount of
protein loaded was optimized for consistent visualization and separation of peaks while
minimizing the required amount of limited biological sample. Figures 2.13 and 2.14
displays chromatograms of protein profiles with loading of either 50 µg or 100 µg of total
protein from parotid saliva. Figures 2.15 and 2.16 displays the same process applied to
unstimulated whole saliva.
The detection sensitivity of the HPLC with the optimized method for C4 RP-HPLC
column was determined through the use of isolated protein (albumin) loaded in known
concentrations. The resulting single peak in each chromatogram was integrated to
relate the area under the curve (AUC) with the amount of protein loaded. This forms the
basis for quantitative analysis of visualized peaks in sample-derived chromatograms by
relating peak size with a previously quantified value. The results of the relationship
between the area under the curve and amount of isolated albumin protein over a range
of concentrations (1.25µg–25µg) are displayed in Figure 2.17, with the raw
chromatograms included in Appendix 4.
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Figure 2.13 - Triplicate chromatograms produced by loading a total of 50 µg of parotid saliva
TM
protein on the C4 XBridge column. The chromatograms display the pattern of isolated parotid
saliva separated on the reverse-phase C4 column run with a method of increasing organic solvent
to a final concentration of 55% acetonitrile and 0.1% TFA.
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Figure 2.14 - Triplicate chromatograms produced by loading a total of 100 µg of parotid saliva
TM
protein on the C4 XBridge column. The chromatograms display the pattern of isolated parotid
saliva separated on the reverse-phase C4 column run with a method of increasing organic solvent
to a final concentration of 55% acetonitrile and 0.1% TFA.
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Figure 2.15 - Triplicate chromatograms produced by loading a total of 50 µg of unstimulated whole
TM
saliva protein on the C4 XBridge
column. The chromatograms display the pattern of
unstimulated whole saliva separated on the reverse-phase C4 column run with a method of
increasing organic solvent to a final concentration of 55% acetonitrile and 0.1% TFA.
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Figure 2.16 – Triplicate chromatograms produced by loading a total of 100 µg of unstimulated
TM
whole saliva protein on the C4 XBridge column. The chromatograms display the pattern of
unstimulated whole saliva separated on the reverse-phase C4 column run with a method of
increasing organic solvent to a final concentration of 55% acetonitrile and 0.1% TFA.
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Figure 2.17 - Relationship between area under the curve and amount of HSA loaded onto the C4
TM
XBridge column. The area under the curve (AU*time) was measured for quantities of HSA
ranging from 5 – 60 µg.
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Figure 2.18 – Chromatograms A, B, C, and D, represent 100 µg of pooled unstimulated whole saliva from Groups A (Children pre-dental
eruption), B (Children during dental eruption), C (Children post dental eruption), and D (Adult controls), respectively, on a C4 X-Bridge
reverse-phase column. The chromatograms display the pattern of unstimulated whole saliva separated on the reverse-phase C4 column
run with a method of increasing organic solvent to a final concentration of 55% acetonitrile and 0.1% TFA. A minimum of ten of the most
prominent and shared peaks from each chromatogram were highlight for comparison between groups.
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Once the method was proven to be consistent and able to successfully separate
the proteins found in unstimulated whole saliva, the pooled unstimulated whole saliva
samples from each of the four groups were loaded and chromatograms compared.
Figure 2.18 displays an overview of the entire 90-minute method for all four groups.
Appendix 5 includes more detailed views of the chromatographic patterns throughout
the length of the chromatographic run.
2.3.8 Mass spectrometric analysis
Mass spectrometric results are summarized in Table 2.5. A total of 79 proteins
were successfully identified in one or more of the four pooled sample groups. A total of
48, 48, 58, and 50 proteins were successfully identified in pooled samples from Groups
A, B, C, and D, respectively.
Table 2.6 summarizes the quantification of relative abundance of the top 15
identified proteins by Scaffold with a minimum cut-off of 2 unique peptide counts, if a
peptide was detected at all. In this study, the count of unique peptides represents the
number of unique parent ions, identified for a protein, that meet the default minimum
intensity limit for MS/MS analysis. The term spectrum counts represents the total
number of MS/MS fragmentation spectra that map to peptides of a given protein.
Unique spectrum counts is the sum of nonrepeated MS/MS fragmentation spectra,
represented as a subset of the total spectrum counts.

Table 2.5 –Mass spectrometric protein identifications for children pre-, during, post-eruption, and edentulous adults, Groups A, B, C, D,
respectively. This table summarizes the name, accession number, molecular weight, and number of unique peptide counts, for each of
the 79 identified proteins, across Groups A, B, C, and D. The numbers corresponding to each protein identified in each group
represents the number of unique peptide counts. The MS/MS results were analyzed using Mascot (version 2.2) and X! Tandem (version
2007.01.01.1), and searched against the NCBInr database. Scaffold (version Scaffold_2_06_02) was used to validate the search results,
with an acceptable peptide probability of greater than 95.0%. The number zero (0) indicates no peptides were detected from the
specified protein.

#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

Identified Proteins (79)
Chain A, Structure Solution And Refinement Of The Recombinant Human Salivary Amylase
albumin, isoform CRA_h [Homo sapiens]
peptide PB,saliva
mucin-5B precursor [Homo sapiens]
unnamed protein product [Homo sapiens]
Polymeric immunoglobulin receptor [Homo sapiens], transmembrane secretory component
parotid secretory protein [Homo sapiens]
unnamed protein product [Homo sapiens]
hypothetical protein LOC352999 precursor [Homo sapiens]
carbonic anhydrase VI [Homo sapiens]
Chain B, Mhc-Like Zinc Alpha2-Glycoprotein And Prolactin Inducible Protein
Mucin 7, secreted [Homo sapiens]
Chain A, Zn-Alpha-2-Glycoprotein
lactoperoxidase isoform 1 preproprotein [Homo sapiens]
lipocalin-1 precursor [Homo sapiens], von Ebner's gland protein
cystatin SA-III=potential precursor of acquired enamel pellicle
actin, beta [Homo sapiens]
bactericidal/permeability-increasing protein-like 1 precursor [Homo sapiens]
small proline-rich protein 3 [Homo sapiens]
deleted in malignant brain tumors 1, isoform CRA_b [Homo sapiens]
cystatin-SA precursor [Homo sapiens]
cystatin-B [Homo sapiens]
cystatin-SN precursor [Homo sapiens]
unnamed protein product [Homo sapiens]
immunoglobulin light chain [Homo sapiens]
suprabasin isoform 1 precursor [Homo sapiens]
Ig L-chain V-region [Homo sapiens]
unnamed protein product [Homo sapiens]
Chain A, Human Cystatin C
transcobalamin-1 precursor [Homo sapiens]
beta-casein [Homo sapiens]
beta-2-microglobulin precursor [Homo sapiens]
cystatin D [Homo sapiens]
Chain B, T-To-T(High) Quaternary Transitions In Human Hemoglobin
Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human
Lysozyme
keratin 1 [Homo sapiens]
monoclonal IgM antibody heavy chain [Homo sapiens]
histatin-1 precursor [Homo sapiens]

Accession Number
gi|14719766 (+1)
gi|119626071 (+11)
gi|350218
gi|301172750
gi|189053131 (+2)
gi|238236 (+2)
gi|16755850 (+1)
gi|14042015
gi|58219024
gi|119592012
gi|145579641
gi|19343619 (+1)
gi|58176763
gi|40549418
gi|4504963
gi|235948 (+1)
gi|14250401 (+9)
gi|15055535 (+1)
gi|4885607 (+3)
gi|119569694 (+14)
gi|4503105
gi|4503117
gi|19882251 (+1)
gi|158256038 (+2)
gi|149673889
gi|260436922
gi|27552515 (+1)
gi|158261509 (+3)
gi|14278690 (+1)
gi|21071008
gi|288098 (+1)
gi|114319049 (+23)
gi|398711 (+1)
gi|60594354 (+30)

Molecular
Weight
56 kDa
69 kDa
6 kDa
596 kDa
19 kDa
83 kDa
27 kDa
53 kDa
38 kDa
35 kDa
14 kDa
39 kDa
32 kDa
80 kDa
19 kDa
14 kDa
41 kDa
49 kDa
18 kDa
178 kDa
16 kDa
11 kDa
16 kDa
54 kDa
23 kDa
61 kDa
23 kDa
52 kDa
13 kDa
48 kDa
25 kDa
12 kDa
16 kDa
16 kDa

gi|6730358
gi|11935049 (+3)
gi|41388180
gi|4504529

15 kDa
66 kDa
64 kDa
7 kDa

Group
A
37
12
7
16
10
11
12
7
8
7
5
9
5
12
8
1
2
4
3
6
1
4
1
2
1
4
1
3
2
4
8
3
0
0

Group
B
34
20
10
11
8
11
7
9
6
7
6
7
7
2
10
7
5
3
0
3
4
4
3
2
3
1
3
7
1
1
0
3
2
0

Group
C
37
20
14
11
12
11
8
10
10
6
6
4
7
4
5
7
8
4
6
5
6
3
4
3
4
4
5
1
5
1
0
2
3
7

Group
D
23
12
14
7
10
6
7
7
6
6
6
3
4
5
0
7
2
5
7
2
4
4
5
5
3
2
2
0
1
3
0
0
2
0

2
1
0
3

2
1
3
1

1
2
3
0

1
2
0
1

Table 2.5 (Continued):
#
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79

Identified Proteins (79)
salivary proline-rich protein precursor [Homo sapiens]
hCG2006898 [Homo sapiens]
hypothetical protein [Homo sapiens]
immunoglobulin J chain [Homo sapiens]
PREDICTED: nucleobindin 2 isoform 2 [Pan troglodytes]
peptide,salivary low MW
hemoglobin alpha-1 globin chain [Homo sapiens]
Chain A, Crystal Structure Of Pi Class Glutathione Transferase
kallikrein 1, renal/pancreas/salivary, isoform CRA_b [Homo sapiens]
RecName: Full=Ig kappa chain C region [Homo sapiens]
Chain A, Crystal Structure Of Human Enolase 1
lactotransferrin [Homo sapiens]
unnamed protein product [Homo sapiens]
beta-casein [Homo sapiens]
RecName: Full=Vitamin D-binding protein [Homo sapiens]
hypothetical LOC389429, isoform CRA_a [Homo sapiens]
alpha-2-macroglobulin-like 1, isoform CRA_b [Homo sapiens]
albumin, isoform CRA_p [Homo sapiens]
cystatin-A [Homo sapiens]
unnamed protein product [Homo sapiens]
Chain A, Apo-Human Serum Transferrin (Non-Glycosylated)
unnamed protein product [Homo sapiens]
Chain A, Alpha-Lactalbumin [Homo sapiens]
immunoglobulin variable region [Homo sapiens]
desmoglein-3 preproprotein [Homo sapiens]
Chain A, High Resolution Crystal Structure Of The Unliganded Human Acbp
extracellular glycoprotein lacritin precursor [Homo sapiens]
mammaglobin-B precursor [Homo sapiens]
cysteine-rich secretory protein 3 [Homo sapiens]
basic salivary proline-rich protein 3 precursor [Homo sapiens]
alpha-amylase [Homo sapiens]
interleukin-1 receptor antagonist protein isoform 3 [Homo sapiens]
unnamed protein product [Homo sapiens]
Chain A, Mixed Disulfide Intermediate Between Mutant Human Thioredoxin And A 13 Residue Peptide
hypothetical protein LOC644054 [Homo sapiens]
glyceraldehyde-3-phosphate dehydrogenase, isoform CRA_a [Homo sapiens]
complement C3 precursor [Homo sapiens]
unnamed protein product [Homo sapiens]
secretoglobin family 1D member 1 precursor [Homo sapiens]
Casein alpha s1 [Homo sapiens]
lectin, galactoside-binding, soluble, 3 binding protein, isoform CRA_a [Homo sapiens]

Accession Number
gi|190510
gi|119571628
gi|34365139
gi|114319027 (+2)
gi|114636384 (+5)
gi|223364
gi|13650074 (+16)
gi|11514448 (+22)
gi|119592319 (+10)
gi|125145 (+2)
gi|203282367 (+5)
gi|119585171 (+28)
gi|189053201 (+3)
gi|29674
gi|139641 (+9)
gi|119568478
gi|119609009 (+4)
gi|119626079 (+2)
gi|4885165
gi|194387966 (+3)
gi|110590597
gi|34526199
gi|157829683 (+2)
gi|323432327
gi|119964718 (+2)
gi|118137768 (+1)
gi|15187164
gi|4505171
gi|119624753 (+6)
gi|117306167 (+4)
gi|178585
gi|10835147 (+5)
gi|158256510
gi|1065111 (+15)
gi|212276011 (+1)
gi|119609192 (+7)
gi|115298678 (+2)
gi|194373909 (+5)
gi|5729907
gi|118764211 (+6)
gi|119609949 (+7)

Molecular
Weight
25 kDa
16 kDa
52 kDa
20 kDa
50 kDa
1 kDa
15 kDa
23 kDa
24 kDa
12 kDa
47 kDa
78 kDa
13 kDa
7 kDa
53 kDa
31 kDa
161 kDa
23 kDa
11 kDa
17 kDa
75 kDa
53 kDa
14 kDa
15 kDa
108 kDa
10 kDa
14 kDa
11 kDa
26 kDa
31 kDa
58 kDa
18 kDa
68 kDa
12 kDa
9 kDa
35 kDa
187 kDa
51 kDa
10 kDa
22 kDa
65 kDa

Group
A
0
1
2
1
2
1
0
2
0
0
0
3
0
3
0
0
0
1
0
0
0
0
2
0
0
0
0
0
2
0
2
0
0
0
0
0
0
0
0
1
0

Group
B
2
0
1
2
0
1
0
0
0
0
0
1
0
0
2
2
1
0
0
0
0
1
0
1
0
0
2
2
0
0
0
0
0
0
0
0
0
0
1
0
0

Group
C
0
1
1
2
2
2
4
0
2
2
3
0
1
0
1
1
0
2
0
1
3
1
0
1
2
0
0
0
0
0
0
0
0
0
0
2
1
1
0
0
1

Group
D
3
3
1
0
1
0
0
2
2
2
1
0
3
0
0
0
2
0
3
2
0
0
0
0
0
2
0
0
0
2
0
2
2
2
2
0
0
0
0
0
0
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Figure 2.19 – Venn Diagrams describing the number of proteins identified in Group A (Children
pre-dental eruption), B (Children during dental eruption), C (Children post dental eruption), and D
(Adult controls). a) TOP Venn Diagram represents the number of proteins identified in the four
groups with a minimum of 1 or more unique peptides identified with MS/MS. b) BOTTOM Venn
Diagram represents the number of proteins identified in the four groups with a minimum of 3 or
more unique peptides identified with MS/MS.
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a)

b)

Table 2.6 – Summary of 15 most abundant proteins from mass spectrometric protein identifications for children pre-, during, posteruption, and edentulous adults, Groups A, B, C, D, respectively. This table summarizes the name, molecular weight, number of unique
peptide counts, spectrum counts, and unique spectrum counts for the top 15 most abundant proteins across Groups A, B, C, and D,
identified in Table 2.5. Scaffold (version Scaffold_2_06_02) was used to validate the search results, with an acceptable peptide
probability of greater than 95.0%. The number zero (0) indicates no peptides and therefore no spectra were detected from the specified
protein.
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2.4

Discussion

2.4.1 Importance of Sample Preparation and Experimental Design
Importance of Sample Preparation
Sample preparation, including collection, storage and processing is of
fundamental importance when working with whole saliva. During the analysis of whole
saliva, one must keep in mind the multiple sources that contribute to saliva’s
composition, including host-derived and exogenously introduced substances. Ordinary
activities, such as brushing one’s teeth, may be sufficient activity to cause minor injury
and introduce serum components into whole saliva. Salivary composition is influenced
by enzymatic activity of both host and bacterially derived proteins. This influence can be
mitigated through careful collection, storage and processing techniques. Such
techniques include collecting and storing samples at temperatures that inhibit
metabolism, centrifuging saliva samples immediately after collection to eliminate
bacterial and cellular debris. Adding enzyme inhibitors to collection tubes to prevent
protein cleavage post-collection, as well as during storage and processing is a
potentially useful measure to be taken to protect the biochemical properties of saliva
samples in future studies. The practical aspects of sample collection and analysis are of
fundamental importance to the completion and interpretation of this thesis and salivary
research as a whole.
The effects of quality handling of samples on the biochemical properties and
composition of saliva should not be underestimated. This is especially the case when
dealing with studies in children. As was the case in this research, the precisely
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controlled and monitored collection of unstimulated whole saliva samples from healthy
children presented more challenges in some respects than the collection of
unstimulated whole saliva from adult controls. It was imperative to maintain a consistent
collection protocol in all sample collections, including the requirement of all collections
to be performed: during the same limited window of time during the day, from individuals
in good health who had not had anything to eat or drink for a full hour before the time of
collection, for all individuals to be at rest before collection starts and to maintain the
state of rest until sample collection is completed, and for all individuals to be free of
medications. The significance of ensuring all individuals were free of medications is
outlined later in this discussion. Ensuring all of these criteria were fully met for each
collection was a source of difficulty in collecting saliva from children. Special mention is
given to the challenge of the maintenance of a restful state in very young children
before and during saliva collection.
Being aware of, and controlling as many variables as possible in the collection
process reduces the number of potential confounders that may affect the composition of
saliva unrelated to the hypothesis being tested, such as the variation in the salivary
proteome with age/developmental stage, at the focus of this work.
Once collected, the processing of samples became of primary importance.
Salivary samples were never left at room temperature during processing or storage.
Unless the samples were actively being processed, they were kept frozen. The handling
of saliva requires mindful planning of the number of times a single saliva sample
requires freezing and thawing. During the freeze-thaw cycle, some salivary proteins
(namely the large glycoproteins of the mucin family) come out of solution. The
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precipitation of proteins out of solution can be greatly prevented through limiting the
number of freezes and thaws experienced by a sample. Samples can generally be
safely frozen twice before any noticeable changes in the consistency of the saliva
appears.
A consideration to keep in mind is the importance of standardizing methods of
sample collection and processing between studies to enable wide-scale comparison of
findings. A standard method of processing whole saliva samples described throughout
the literature includes the centrifugation of samples followed by the collection and
analysis of the supernatant. The whitish pellet that remains at the bottom of the
centrifuged tube is rarely discussed. The composition of the pellet may also prove to be
a useful source of biological information, as proteins and other molecules of potential
interest, may be trapped in the debris.
Importance of Experimental Design
The selection of techniques in this study of the changes in the salivary proteome
during the course of dental eruption was designed to offer as much useful information
as possible with the amount of samples collected. As previously mentioned, both 1- and
2-dimensional PAGE (1D- and 2D-PAGE) are effective methods of protein separation
and have been widely used to separate salivary proteins

(4, 6, 14, 29, 81). Both

methods provide visuals of profiles of protein mixtures that can be used to assess
variability between samples, people, and groups. 2D-PAGE is a powerful technique of
protein separation but harbors significant limitations that remain highly relevant in
salivary protein research. 2D-PAGE is ill suited for the detection of small MW proteins,
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highly acidic or basic proteins, highly hydrophobic proteins, as well as proteins in low
abundance (6). The presence of many small MW proteins and peptides, as well as a
significant number of highly acidic, basic, hydrophobic and proteins present in very low
concentrations in saliva, makes it clear that 2D-PAGE is not of great use to study the
changes in the complete salivary proteome. Instead, two varieties of 1D-PAGE were
employed to separate and visualize proteins in their native state (anionic PAGE) and in
a denatured state (SDS-PAGE). With the use of both the negative charge (anionic) and
molecular weight (SDS) as differentiating characteristics, a third mode of separation and
visualization was then employed. Reverse-phase HPLC was used to separate whole
proteins based on their degree of hydrophobicity. The fourth technique for protein
analysis involved digesting the salivary proteins with trypsin prior to separation via
reverse-phase HPLC inline with the mass spectrometer. This variety of techniques
worked in concert together to maximize the quality and quantity of useful information
and cross-technique validations.
2.4.2 Protein Quantification
Quantification of Total Protein Concentration
In addition to the discussion of quality handling of the saliva samples during
collection, storage and processing, the quantification of protein concentration must be
highlighted. The very first quantification of salivary protein concentration in any sample
in this study was the measurement of total protein concentration. While numerous
methods are available to achieve the quantification of total protein in a sample, saliva’s
varied and complex composition, as well as the large normal range of total protein
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concentration, narrows the selection of appropriate protein concentration assays. This
work compared the results of two well-established protein quantification methods, the
Bradford assay and the BCA assay. The most suitable protein quantification assays are
those in which the properties being measured are equally distributed within all samples.
The BCA assay’s detection of peptides bonds and four amino acids in salivary samples
is much more representative of the total protein concentration than the less uniformly
distributed hydrophobic and ionic interactions detected by the Bradford method. For this
reason, the BCA assay was selected for this study. Ultimately, the basic salivary
composition greatly guides the selection of the techniques and technologies applicable
to its study. Once the total protein concentration of all the samples were achieved, the
focus shifted to the accurate quantification of individual or subsets of proteins within
saliva, such as those achieved with the quantification of protein profile bands in both
SDS and anionic PAGE experiments.
Quantification of PAGE Band Intensities
The quantification of bands from both types of PAGE (SDS and anionic)
demonstrated clear visual relative quantitative representations of protein profiles for
individuals in all four groups. Anionic PAGE revealed a striking difference in the protein
profile of children with complete dental eruption (Group C), compared to the children
with no dentition (Group A), children with partial dentition (Group B), and adults with no
dentition (Group D) (Figures 2.3 and 2.4). The greatest difference is seen in the section
of the gel with the same relative migration as the human serum albumin control.
Albumin is a major salivary protein derived from serum exudate that enters the oral
cavity at the interface between the teeth and gums through a source known as gingival
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crevicular fluid (GCF). An increase in the number of teeth erupted produces a larger
interface surface between the teeth and gums and therefore a larger the potential
contribution of serum exudate components harbored in GCF.
As expected, the group with the highest number of erupted teeth (Group C) has
the highest concentration of potential HSA. The group with a fewer number of erupted
teeth (Group B) has a notably lower concentration of potential albumin. Lastly, the two
groups with no teeth (Groups A and D) have an even lower concentration of potential
albumin. The relative protein quantification provided by the MS analyses (seen in Table
2.6) are perfectly aligned with this trend of albumin concentration increasing as the
number of teeth increase. These findings serve to highlight the importance of studying
children throughout the course of dental eruption, as clear quantitative changes are
detectable at different stages of development. These changes must be taken into
account prior to development of standard baseline measurements of salivary protein
profiles.
The SDS PAGE also revealed a striking difference in the protein profile of
children at different stages of dental eruption as well as the adult edentulous controls.
Figures 2.6-2.9 suggest the degree of variation between individuals of the same group
(intra-group variability) decreases with age. The greatest differences in the protein
profiles are seen in the youngest children (Group A- approximate age 0-6 months), with
increasingly more conformity to a single protein profile trend as the average age of the
subjects increases (Groups B, C, and finally adults in Group D).
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The inter-group variation summaries displayed in Figures 2.11 and 2.12
illuminate the prominent differences in the average protein profiles of each of the four
groups. While both figures summarize the same information, the data was acquired in
two ways. Figure 2.11 summarizes data of an independent gel loaded with each lane
representing a single group, while Figure 2.12 displays data of summed protein profiles
from different gels (Figure 2.12). While similar conclusions can be drawn from both
summaries, attention is drawn to Figure 2.11, as it provides a more direct comparison of
the protein profiles run simultaneously. As seen in Figure 2.11, Group A (the youngest
children in this study, representing the salivary proteome pre-dental eruption) appears
to have a far greater abundance of large MW proteins (80 kDa or greater) relative to all
the other groups. The relative protein quantification provided by the MS analyses (seen
in Table 2.6) are also perfectly aligned with this observation. The relative abundance of
mucin-5B precursor (596 kDa) is seen in much greater abundance in the youngest
cohort (Group A), than in the other 3 groups. This may indicate a lower amount of
proteolytic cleavage experienced in children with no dentition. In the absence of teeth,
as is the case in Group A, the proteins that are known to adhere to the surface of teeth
are not yet established in a stable or permanent way in the oral environment. With a
decrease in the number of surfaces available for the adherence of proteolytic enzymes,
it is expected to observe a lower concentration of these enzymes and their associated
proteolytic activity. Related to the anionic PAGE results, the SDS PAGE results in
Figure 2.11 displayed the greater abundance of protein at approximately 60 kDa in
Group C relative to all the other groups. HSA, the most abundant protein in blood, has a
known molecular weight of 67 kDa. As underscored previously in the discussion of the
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anionic PAGE results, this striking difference of Group C relative to the other groups
may be an indication a protein derived from GCF, as Group C is the only group with fully
present dentition and therefore a maximum interface of teeth and gums (the entry point
of GCF into saliva).
While these results across PAGE platforms are promising, quantifications of
protein profiles will be more useful once protein identities can be confidently assigned.
To enhance the quality of comparison, and help control for variability between
migrations of samples on different gels, an internal control of a single individual can be
run consistently on all gels.
2.4.3 Protein Separation
As the resolution of separation is increased, an even greater wealth of
information may be derived from the analysis. We were able to separate proteins in
whole saliva based on molecular, negative charge and hydrophobicity. Additional
separation may also be achieved using techniques such as positive charge or protein
binding affinities to further develop the complete picture of the components of the
salivary proteome at different ages.
While

often

very

time-consuming,

method

optimization

with

liquid

chromatography provides very high-resolution separation on a multitude of dimensions,
dependent on column and gradient selection. Chromatograms also allow for the
potential of peak quantification if a panel of isolated proteins may be acquired to
correlate the area under the curve with absorbance for each protein species.
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2.4.4 Proteins Identified
The MS analysis completed in this study resulted in the identification of fewer
than 100 proteins (79 proteins) across all groups. The rather low number of protein
identifications across the four groups could be expanded when greater sample volumes
are collected and made available to repeat the MS runs more than the duplicates
completed in this study. A greater number of runs would further increase the likelihood
of identifying more lower abundance proteins. It is important to note that proteins
present in lower abundance are often of greatest interest in diagnostic testing. A longer
liquid chromatography separation method, from the 80 minutes described in this study
to 2-4 hours, would enhance protein separation, and may result in an increase in the
number of successful protein identification.
Alternative pre-processing of the samples prior to loading on the inline HPLC
may serve to further enhance the number and confidence of protein identifications. Due
to the presence of high-abundance proteins (i.e. albumin, mucin, complement
component proteins), immunodepletion may be used to help reveal proteins in lower
abundance. Mucin is a good candidate to target with immunodepletion because of its
great abundance in whole saliva, its large size (>500 kDa), and extensive glycosylation
making it highly susceptible to aggregation. Immunodepletion, much like any purification
or simplifying measure, may be associated with undesired effects, such as the
elimination of other protein species through non-specific binding, or their close
association with the targeted and eliminated protein.

The detection sensitivity and

quantitation technologies that continue to advance in the MS field have the potential to
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provide a more detailed assessment of differentially expressed proteins in saliva,
especially if the complexity of the samples can be successfully managed.
Even with the limited number of protein identifications, a number of interesting
stories have come to light. For example, beta-casein, a member of a phosphoprotein
family present in mammalian milk, was detected only in the youngest cohort (Group A –
children from approximately 0-6 months of age). This finding helps to validate the
techniques of sample collection and analysis, as children 0-6 months of age have a diet
primarily composed of mammalian milk.
The relative protein quantification trends provided by the MS analyses (seen in
Table 2.6) serve as rough estimates of trends present in the salivary proteome. More
replicates and greater number of identified peptides and spectra are required to draw
definitive and absolute conclusions. This study describes relative abundance trends in
specific proteins between groups. The relative abundance trends are extracted from
Table 2.6 by comparing the total number of unqiue spectra counts for each protein in
the different groups. As previously defined, unique spectrum counts is the term used to
represent the number of one of a kind MS/MS fragmentation spectra that map to
peptides of a given protein. The number of unqiue spectrum counts may be greater than
the number of unique peptide counts due to the presence of variable modifications,
such as oxidation of methionine. The same unique peptide may be counted as multiple
unique spectra if the variable modifications are present in one spectra, but not in
another. Spectral counting offers a means of comparing protein abundance across
groups, if the same preparation and isolation techniques were applied for each
experiment.
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There are critical considerations to keep in mind when using abundance
comparisons obtained through spectral counting. The first major consideration to
highlight is the appropriate use of inter-group comparisons of a given protein, rather
than inter-protein comparisons even within the same group, which are not reliable.
Abundance comparisons through spectral counting does not allow for a proper
comparison of different proteins and their relative abundance. This is due to technical
considerations of MS-based approaches that depend on the efficiency of protein
digestion (related to size, and number of lysine and arginine residues, etc.), the
ionization efficiency, and the quality of HPLC separation (i.e. presence of co-elution). It
is for this reason that the rank order of the top 15 quantified proteins is not emphasized
significantly, but rather the focus is given to the relative abundance of a single protein
between different groups. Comparing the relative abundance of one protein with another
even within the same group requires careful attention and validation, due to the points
mentioned above. The quality of HPLC separation, and presence of co-elutioning
proteins is also a point of consideration for valid inter-group comparisons of a given
protein, as the variable composition of samples between groups can serve to mask a
protein in some groups but not equally in others.
Despite the issues associated with reliability of protein abundance comparison,
spectral counting provides a reasonable estimation method for ball-park global
quantification of abundant proteins. The results that were achieved in this study serve
as a good reference point from which to continue exploring. The following paragraphs
highlight the most significant findings in abundance trends, as determined by the
quantification of unique peptide and spectrum counts. The use of unqiue ion counts is
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another very valid route to describe these findings, and is preferred by some
researchers. For the purpose of this analysis and as is often the case, both
measurements result in the same relative rank order of the top most abundant identified
proteins, and resultant abundance trends. The cut-off determined for categorizing the
top 15 proteins (as displayed in Figure 2.6) was determined by the minimum unique
peptide count set at 2, if a peptide was detected at all.
Amylase (56 kDa) was found to be in lowest abundance in the adult controls
(Group D), relative to all the child cohorts (Groups A, B, and C). The highest abundance
of amylase was observed in children post dental eruption (Group C). This could reflect
the requirement of higher amylase concentrations in individuals with complete dentition,
as amylase functions to prevent bacterial attachment to the tooth surface and assist in
bacterial clearance.
Albumin’s (69 kDa) relative abundance trend serves as an excellent example of
cross-technique validation in this study. The relative MS quantification of albumin
validates the findings from the anionic gels, as the relative abundance of albumin
increases as the number of erupted teeth increases. Albumin’s abundance is nearly 2fold greater in children with all of their primary dentition (Group C), relative to children
pre-dental eruption (Group A). The relative abundance of albumin in Group B (children
during dental eruption) is between that of Group A and Group C, as to be expected if
the albumin concentration is related to the potential GCF contribution in children with
teeth versus children without any teeth.
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Lactoperoxidase isoform 1 preproprotein (80 kDa) was detected in the youngest
group (Group A) with approximately a two-fold greater abundance than in all the other
groups (Groups B, C, and D). The presence of this lactoperoxidase precursor molecule
in saliva is not a surprise, as lactoperoxidase is a well-known endogenous salivary
protein produced by the salivary glands. Lactoperoxidase is one of the two major
peroxidases in whole saliva, along with myeloperoxidase, functioning primarily as an
anti-bacterial agent. The heighten abundance of this innate immune molecule in the
youngest group (Group A) is again well inline with the large innate immune response in
infants, that compensates for their weaker adaptive immune system which is not fully
developed in the first few months of life.
As previously mentioned, the relative abundance of mucin (mucin-5B precursor,
and mucin 7) is highest in children pre-dental eruption (Group A), relative to all the other
groups, as suggested and described in the SDS-PAGE results.
Von Ebner’s gland protein (19 kDa) was detected in all the children groups
(Group A, B, and C), but not in the edentulous adult controls (Group D). This finding has
not previously been documented.
The following proteins were not seen to change dramatically between the four
groups: Carbonic anhydrase VI (35 kDa), Prolactin Inducible Protein, unnamed protein
products with a MW of 53 kDa and 19 kDa, and a hypothetical protein of 38 kDa. The
unnamed protein products and hypothetical protein are good candidates for further
interaction studies, as very little is known about them and their functions in whole saliva.
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To enable the further relative and absolute quantitative measurements of salivary
proteins in different groups, proteins may be labeled prior to separation and mass
spectrometry. Protein labeling (iTRAQ) was attempted during the course of this work but
required more biological samples than were presently available from the collection from
all individuals to return meaningful results. Through the combination of immunodepletion
to increase the probability of low abundance protein identification, as well as protein
labeling, more meaningful quantitative results of a panel of salivary proteins may be
achieved.
2.4.5 Future Work
The motivation for identifying and understanding the changes in the salivary
proteome for all ages in health or pathology is to lay the groundwork for the
development of diagnostic tools to assess the physiological state of individuals through
non-invasive salivary testing. Understanding the differences in salivary proteins and the
salivary proteome present throughout life in health and disease is a necessity to
accurately identify salivary protein-drug interactions, to accurately measure salivary
drug concentrations and identify disease markers in saliva.
The advancement of useful clinical tools must be firmly planted in an
understanding of the biochemistry of saliva and the ways in which composition is altered
with age, states of health and presence or absence of drugs. The work with
unstimulated saliva from healthy individuals, such as that of this research, is truly the
foundation that must be set before the study of the changes in composition of the
salivary proteome can be expanded to include diseased states and drug-induced
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changes in salivary biochemistry. The recognition of a drugs ability to alter the salivary
proteome is of tremendous importance, especially in the development of drug-specific
assays for the monitoring of drug concentrations in saliva.
Some of the most helpful advances in salivary research are those that bring to
light the often unmentioned considerations that are critical to producing reproducible
and meaningful results. This study encourages future work to be mindful of the careful
monitoring of salivary sample collection, storage and processing techniques. Future
work must recognize the importance of careful selection of individuals free of
medications, as this is imperative at this stage of analysis. Many drugs are able to
interfere with the process of salivary secretion, as well as binding salivary proteins.
Much attention is needed to elucidate the drug-associated changes in the salivary
proteome, once a healthy baseline is confidently identified at different ages and states.
To achieve this aim, future work is needed with a focus on the determination of
protein identities separated with PAGE and liquid chromatography. The use of mass
spectrometric identification of proteins can allow us to better elucidate differences,
specifically in young children who have been seen here to have notably unique salivary
protein profiles as compared not only with adult controls, but also between
developmental stages in children as dental eruption events unfold.
We must remain conscious of the developmental stage of an individual as we
work towards future diagnostic test development. As seen in this study, age plays a
noticeable role in the salivary protein profile. This age-specific focus on protein profiling
needs to be continued to provide a higher resolution image of the dynamic changes in
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the salivary proteome. In future studies, the close monitoring of the age and
developmental stage (i.e. pre- or post-dental eruption) of an individual will be very useful
to account for and limit the variation of the protein profile related to age. More replicates
are needed to draw definitive conclusions on the relative and absolute quantified
changes in the salivary proteome. A greater sample size (n > 48 per group), as
determined by this study, and larger sample volumes will serve to increase the amount
of testing possible, and as a result, increasing the quantity of findings and confidence in
future studies.
Once a more comprehensive description of the changing salivary proteome in
healthy children is achieved, protein profiles of children with specific pathologies may be
compared to identify presence of any distinguishing salivary protein markers. The
greater degree of protein profile variability observed in this study in children 0-6 months
of age, relative to children 6 months-3 years of age, as well as adult controls, will
hopefully stir further excitement and enthusiasm in the efforts focused on uncovering of
the complexities of the dynamic nature of the salivary proteome in the youngest of
children. It is this youngest cohort that may benefit the most from repeated non-invasive
and pain-free salivary diagnostics to inform clinical decisions. With a better
understanding, salivary protein markers may then be further explored for relevance in
diagnostic, prognostic and/or condition/treatment monitoring tests. This will provide
insights into the potential use of salivary drug concentrations for therapeutic drug
monitoring in children.
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By addressing the limitations of this present research, future efforts can build on
this knowledge and continue to move the field of salivary biochemistry, and ultimately
salivary diagnostics in children, forward and into the medical and dental clinics.
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Appendix 3
Results
Table A3.1 - Clinical data summary – Inter-group Age Comparison
Clinical Data Inter-group Age Comparison
AGE
Group A
Age
Standard
(months)
Error

N
Mean
95% CI for Mean
Lower Bound
Upper Bound
5% Trimmed Mean
Median
Variance
Standard Deviation
Minimum
Maximum
Range
Interquartile Range
Skewness
Kurtosis

12
4.667
3.383
5.951
4.755
5.125
4.083
2.021
0.750
7.000
6.250
3.750
-0.600
-0.737

Group B
Age
Standard
(months)
Error

0.583

10
14.200

0.637
1.232

10.180
18.220
14.153
14.625
31.581
5.620
6.250
23.000
16.750
10.440
-0.052
0.942

1.777

Group C
Age
Standard
(months)
Error

12
34.167
37.822
30.511
37.822
34.324
33.625
5.754
23.500
42.000
18.500
9.440
-0.230
-0.773

Group D
Age
Standard
(months)
Error

1.661

10
597.491

33.490

0.637
1.232

521.731
673.251
599.379
612.480
11215.852
105.905
420.000
741.000
321.000
167.260
-0.479
-0.728

0.687
1.334

Table A3.2 - Clinical data summary – Inter-group Total Protein Comparison
Clinical Data Inter-group Total Protein Comparison
TOTAL PROTEIN CONCENTRATION
Group A
Total
protein
Standard
(µg/mL)
Error

N
Mean
95% CI for Mean
Lower Bound
Upper Bound
5% Trimmed Mean
Median
Standard Deviation
Minimum
Maximum
Range
Interquartile Range
Skewness
Kurtosis

12.0
699.4
436.3
962.4
670.7
553.5
414.0
235.5
1679.3
1443.8
467.1
1.3
1.8

Group B
Total
protein
Standard
(µg/mL)
Error

119.5

10.0
921.4

0.6
1.2

326.7
1516.0
826.3
697.1
831.2
346.7
3207.3
2860.6
509.2
2.8
8.2

Group C
Total
protein
Standard
(µg/mL)
Error

Group D
Total
protein
Standard
(µg/mL)
Error

262.9

12.0
1019.2

83.1

10.0
1655.0

454.6

0.7
1.3

836.4
1202.0
1022.5
980.1
287.7
495.6
1484.2
988.6
471.9
0.0
-0.5

0.6
1.2

672.0
2638.0
1493.0
1287.5
1374.2
826.9
5398.9
4572.0
854.5
2.7
7.8

0.7
1.3
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Table A3.3 - Clinical data summary – Inter-group Volume of Saliva Comparison
Clinical Data Inter-group Volume of Saliva Comparison
VOLUME OF SALIVA
Group A
Volume of
Standard
Saliva (mL)
Error

N
Mean
95% CI for Mean
Lower Bound
Upper Bound
5% Trimmed Mean
Median
Variance
Standard Deviation
Minimum
Maximum
Range
Interquartile Range
Skewness
Kurtosis

12
0.404
0.280
0.529
0.402
0.450
0.038
0.196
0.050
0.800
0.750
0.280
0.056
0.703

Group B
Volume of
Standard
Saliva (mL)
Error

0.057

10
0.300

0.637
1.232

0.165
0.435
0.294
0.250
0.036
0.189
0.100
0.600
0.500
0.400
0.373
-1.508

Group C
Volume of
Standard
Saliva (mL)
Error

0.060

12
0.371

0.687
1.334

0.262
0.480
0.373
0.450
0.029
0.171
0.100
0.600
0.500
0.300
-0.394
-1.530

Group D
Volume of
Standard
Saliva (mL)
Error

0.049

10
1.280

0.335

0.637
1.232

0.523
2.037
1.244
1.000
1.120
1.058
0.200
3.000
2.800
2.080
0.441
-1.481

0.687
1.334

Table A3.4 - Clinical data summary – Inter-group Number of Teeth Erupted Comparison
Clinical Data Number of Teeth Erupted
TEETH ERUPTED
Group A
Teeth Erupted
(#)

N
Mean
95% CI for Mean
Lower Bound
Upper Bound
5% Trimmed Mean
Median
Variance
Standard Deviation
Minimum
Maximum
Range
Interquartile Range
Skewness
Kurtosis

Group B
Teeth Erupted
Standard
(#)
Error

12
0

10
8

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

4.0529
11.9471
7.9444
6.5
30.444
5.51765
1
16
15
11
0.496
-1.166

Group C
Teeth Erupted
(#)

Group D
Teeth Erupted
(#)

1.74483

12
20

10
0

0.687
1.334

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
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Table A3.5 - Nonparametric Correlations - Age and Protein Concentration
Spearman's rho
Protein
Concentration

Age
Age

Protein Concentration

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

1

0.48**
0.001
44
1

44
0.48**
0.001
44

44

** Correlation is significant at the level of 0.01 (2-tailed)

Table A3.6 - Nonparametric Correlations – Protein Concentration and Age in Females
Spearman's rho
Protein
Concentration
Protein Concentration

Age

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

1
18
0.635**
0.005
18

Age
0.635**
0.005
18
1
18

** Correlation is significant at the level of 0.01 (2-tailed)

Table A3.7 - Nonparametric Correlations - Protein Concentration and Age in Males
Spearman's rho
Protein
Concentration
Protein Concentration

Age

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

** Correlation is significant at the level of 0.05 (2-tailed)

1
26
0.42**
0.033
26

Age
0.42**
0.033
26
1
26

131
Table A3.8 - Nonparametric Correlations – Volume of Saliva and Protein Concentration
Spearman's rho
Volume of
Saliva
Volume of Saliva

Protein Concentration

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

Protein
Concentration

1

0.066
0.672
44
1

44
0.066
0.672
44

44

Table A3.9 - Nonparametric Correlations – Age and Volume of Saliva
Spearman's rho
Volume of
Saliva

Age
Age

Volume of Saliva

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

1

0.252
0.098
44
1

44
0.252
0.098
44

44

Table A3.10 - Nonparametric Correlations – Protein Concentration and Teeth Erupted
Spearman's rho
Protein
Concentration
Protein Concentration

Teeth Erupted

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

1
44
0.067
0.668
44

Teeth Erupted
0.067
0.668
44
1
44

132
Table A3.11 - Nonparametric Correlations – Protein Concentration and Teeth Erupted in
Females
Spearman's rho
Protein
Concentration
Protein Concentration

Teeth Erupted

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

1
18
0.184
0.464
18

Teeth Erupted
0.184
0.464
18
1
18

Table A3.12 - Nonparametric Correlations – Protein Concentration and Teeth Erupted in
Males
Spearman's
Spearman's rho
Protein
Concentration
Protein Concentration

Teeth Erupted

Correlation Coefficient
Significance (2-tailed)
N
Correlation Coefficient
Significance (2-tailed)
N

1
26
-0.021
0.918
26

Teeth Erupted
-0.021
0.918
26
1
26

Table A3.13 - Nonparametric Tests – Hypothesis Test Summary – Kruskal-Wallis
Hypothesis Test Summary
Null Hypothesis
Test
The distribution of Age is the same
1
Independent-Samples Kruskal-Wallis Test
across all Groups
The distribution of Protein Concentration
2
Independent-Samples Kruskal-Wallis Test
is the same across all groups
The distribution of Volume of Saliva is the
3
Independent-Samples Kruskal-Wallis Test
same across all Groups
The distribution of Teeth Erupted is the
4
Independent-Samples Kruskal-Wallis Test
same across all Groups
Asymptotic significances are displayed. The significant level is 0.05.

Significance

Decision

0

Reject the null hypothesis

0.598

Retain the null hypothesis

0.266

Retain the null hypothesis

0

Reject the null hypothesis

Table A3.14 - Nonparametric Tests – Hypothesis Test Summary – Mann-Whitney U
Hypothesis Test Summary
Test

Null Hypothesis
The distribution of Age is the same
Independent-Samples Mann-Whitney U Test
1
across all Groups
The distribution of Protein Concentration
Independent-Samples Mann-Whitney U Test
2
is the same across all groups
The distribution of Volume of Saliva is the
Independent-Samples Mann-Whitney U Test
3
same across all Groups
The distribution of Teeth Erupted is the
Independent-Samples Mann-Whitney U Test
4
same across all Groups
Asymptotic significances are displayed. The significant level is 0.05.

Significance

Decision

0

Reject the null hypothesis

0.024

Reject the null hypothesis

0.81

Retain the null hypothesis

0

Reject the null hypothesis
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Appendix 4
Results – HSA Area under the curve of chromatograms
25ug BSA stnd from BCA kit
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Appendix 5
Results – Unstimulated whole saliva chromatograms

146

Appendix 6
Details of calculation for future sample size recommendation for comparison using two
independent means as mentioned in Section 2.2.3 and described by Altman DG,
Machin D, Bryant TN, Gardner MJ. Statistics with confidence, 2nd edition. BMJ Books,
2000.
n = 2 * (Z1-α/2 + Z1-β)2 * σ2 / ∆2
n = 2 * (1.96 + 0.84)2 * 3502 / 2002
n = 2 * 7.84 * 122,500 / 40,000
n = 48.02 or 48 per group
Conclusion: 48 subjects are needed in each group to have an 80% chance of detecting
a clinically meaningful difference in total protein concentration of 200 ug/mL between
groups, assuming an alpha of 0.05, and a standard deviation of 350 ug/mL.
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